Is Aphria Still the Top Canadian Cannabis Stock?

: APHA | Aphria Inc. Common Shares News, Ratings, and Charts

APHA – Aphria (APHA) has been able to outpace its competitors in terms of revenue and price performance. But, is it still the top Canadian cannabis stock? Read more to learn how APHA’s business model has set it up for long-term success.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

A canadian cannabis stock that stands above the rest is Aphria (APHA). Compared to its competitors, Canopy Growth (CGC) and Aurora Cannabis (ACB), APHA already has a track record of success. While CGC and ACB have been struggling to write down goodwill due to high-priced acquisitions, APHA has avoided pricey acquisitions and kept a healthy balance sheet and a substantial amount of cash.

APHA has a strong record of sales growth. Its five-year revenue growth average is 206.2%. This is due to its portfolio of brands such as Aphria, Broken Coast, Solei, RIFF, and Good Supply. In its last reported results, net cannabis revenue was up 81% from the prior quarter. This is due to robust volume growth. The cost per dried gram remained low at CAD 0.88. This led to increased profitability for the company. Its adjusted EBITDA was up 49% from the third quarter, to CAD $8.6 million. APHA is currently the only Canadian cannabis producer that generates positive EBITDA.

Unlike its competitors, which sell consumer packaged goods, APHA focuses on flower and vape products. The company also had an extensive international distribution business, which has primarily driven revenue. APHA has operations in ten countries outside Canada. The company’s German subsidiary, CC Pharma, which it acquired last year, has access to nearly 70% of pharmacies in Germany.

APHA is No. 1 in terms of net revenue across all Canadian cannabis companies and it should continue to be for the foreseeable future.  The company is going after the cannabis derivatives market. Derivatives are products such as edibles, cannabis-infused beverages, concentrates, topicals, and vapes. These were made legal in Canada late last year. Previously, only dried flower and cannabis oil were legal. The derivatives market is potentially more lucrative as margins are better. APHA is already the leading derivatives provider in Ontario.

APHA also has one of the best management teams in the industry with CEO Irwin Simon leading the company. Simon has put an emphasis on core business in the Canadian marketplace. 

Though APHA’s performance year-to-date (YTD) is lackluster, -11%, it is significantly outperforming the ETFMG Alternative Harvest ETF (MJ), which is down more than 33% YTD.  It is currently rated a “Strong Buy” by Wall St. analysts, with an average price target of $7.19, which represents a 53% increase from where it currently trades. 

As you can see, APHA stands atop the Canadian cannabis sector.  If you are a long-term investor, you may want to consider adding this strong cannabis stock to your portfolio.

Disclosure: The author is long APHA.

Want More Great Investing Ideas?

7 Best ETFs for the NEXT Bull Market

Is the Stock Market Correction Over?

Chart of the Day- See the Stocks Ready to Breakout


APHA shares were trading at $4.68 per share on Tuesday afternoon, up $0.03 (+0.65%). Year-to-date, APHA has declined -10.34%, versus a 7.21% rise in the benchmark S&P 500 index during the same period.


About the Author: Aaron Missere


Aaron is an experienced investor who is also the CEO of Departures Capital. His primary focus is on the cannabis industry. He also hosts a weekly show on YouTube about marijuana stocks. Learn more about Aaron’s background, along with links to his most recent articles. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
APHAGet RatingGet RatingGet Rating
MJGet RatingGet RatingGet Rating

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

When Does the Next Bull Run Start?

The 5 month rally for stocks (SPY) was too much, too soon calling into question whether it indeed was a bubble. Thus, not surprising stocks are seeing a healthy correction in September. What matters now is determining when to buy this dip for the next bull run ahead. That is the focus of today’s commentary.

:  |  News, Ratings, and Charts

Is Now a Good Time to Buy Shares of Carnival Corp.?

Cruise stocks have been the worst-hit by the pandemic. All cruising has been halted in most parts of the world. Also, these companies have high, fixed costs, and they are not generating any sort of revenue. They have been fighting for survival by raising money which will dilute future earnings. However, these poor fundamentals also mean the stocks could have upside when cruising returns. Find out if it's time to buy Carnival Corporation (CCL).

:  |  News, Ratings, and Charts

3 Dividend Stocks with EXPLOSIVE Growth

With the market volatility back, investors typically look towards dividend stocks from safe harbor. But what if you could invest in a dividend stock that exhibits strong growth? Here are 3 dividend stocks with explosive growth: Innovative Industrial Properties (IIPR), Medifast (MED), and China Distance Holdings Limited (DL).

:  |  News, Ratings, and Charts

Is eBay a Buy at $52?

The current sell-off offers an opportunity to buy eBay (EBAY) at a discounted price. The stock is well positioned to rally based on short- and long-term bullishness, impressive financial performance and a rising popularity of e-commerce platforms.

:  |  News, Ratings, and Charts

3 Dividend Stocks with EXPLOSIVE Growth

With the market volatility back, investors typically look towards dividend stocks from safe harbor. But what if you could invest in a dividend stock that exhibits strong growth? Here are 3 dividend stocks with explosive growth: Innovative Industrial Properties (IIPR), Medifast (MED), and China Distance Holdings Limited (DL).

Read More Stories

More Aphria Inc. Common Shares (APHA) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All APHA News